Chaudhary, Rahul http://orcid.org/0000-0002-3276-385X
Sharma, Tushar
Garg, Jalaj
Sukhi, Ajaypaul
Bliden, Kevin
Tantry, Udaya
Turagam, Mohit
Lakkireddy, Dhanunjaya
Gurbel, Paul
Article History
First Online: 11 September 2019
Compliance with ethical standards
:
: Paul Gurbel reports serving as a consultant for Daiichi Sankyo/Lilly, Bayer, AstraZeneca, Accumetrics, Merck, Medtronic, Janssen, CSL, and Haemonetics; receiving grants from the National Institutes of Health, Daiichi Sankyo, Lilly, CSL, AstraZeneca, Haemonetics, Harvard Clinical Research Institute, and Duke Clinical Research Institute; receiving payment for lectures, including service on speakers’ bureaus, from Lilly, Daiichi Sankyo, and Merck; receiving payment for development of educational presentations from Merck, the Discovery Channel, and Pri-Med; Dr. Gurbel is holding stock or stock options in Merck, Medtronic, and Pfizer; and holding patents in the area of personalized antiplatelet therapy and interventional cardiology. No other authors report any potential conflicts of interest.
: An approval by an ethics committee was not applicable.